Regulatory Controls for Osteoblast Growth and Differentiation: Role of Runx/Cbfa/AML Factors

Critical Reviews in Eukaryotic Gene Expression

Volumn 14, Issue 1-2, 2004, Pages 1-41

  Lian, Jane B ^a   Javed, Amjad ^a   Zaidi, S Kaleem ^a   Lengner, Christopher ^a   Montecino, Martin ^b   Van Wijnen, Andre J ^a   Stein, Janet L ^a   Stein, Gary S ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

Cbfa1 AML3 Runx2; Chromatin remodeling; Combinatorial mechanisms; Gene transcription; Genomic organization; Nuclear targeting; Osteocalcin; Runx coregulatory proteins; Runx1; Runx3

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AML; TRANSCRIPTION FACTOR CBFA; TRANSCRIPTION FACTOR RUNX; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

BONE REMODELING; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CONNECTIVE TISSUE; EMBRYO DEVELOPMENT; GENE EXPRESSION REGULATION; HUMAN; MESENCHYME; OSTEOBLAST; OSTEOCYTE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TRANSLATION INITIATION;

EID: 2342476573     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/critreveukaryotgeneexpr.v14.i12.10     Document Type: Review

References (369)

1. Acampora D, Merlo GR, Paleari L, Zerega B, Postiglione MP, Mantero S, Bober E, Barbieri O, Simeone A, Levi G (1999): Craniofacial, vestibular and bone defects in mice lacking the distal-less-related gene dlx5. Development 126:3795-3809.
2. Afzal F, Zaidi SK, Javed A, van Wijnen AJ, Stein JL, Lian JB, Stein GS (2003): Subnuclear targeting supports functional interrelationships between Runx2 and the BMP-2 regulated Smad 1 protein. J Bone Miner Res 18:S6(Abstract).
3. Ahn MY, Huang G, Bae SC, Wee HJ, Kim WY, Ito Y (1998): Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dc13 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO. Proc Natl Acad Sci U S A 95:1812-1817.
4. Ahuja SS, Zhao S, Bellido T, Plotkin LI, Jimenez F, Bonewald LF (2003): CD40 ligand blocks apoptosis induced by tumor necrosis factor alpha, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4. Endocrinology 144:1761-1769.
5. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B (2002): The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16:2813-2828.
6. Alliston T, Choy L, Ducy P, Karsenty G, Derynck R (2001): TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 20:2254-2272.
7. Aubin JE (2001): Regulation of osteoblast formation and function. Rev Endocr Metab Disord 2:81-94.
8. Babichuk CK, Bleackley RC (1997): Mutational analysis of the murine granzyme B gene promoter in primary T cells and a T cell clone. J Biol Chem 272:18564-18571.
9. Bae SC, Ogawa E, Maruyama M, Oka H, Satake M, Shigesada K, Jenkins NA, Gilbert DJ, Copeland NG, Ito Y (1994): PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol Cell Biol 14:3242-3252.
10. Bae SC, Takahashi E, Zhang YW, Ogawa E, Shigesada K, Namba Y, Satake M, Ito Y (1995): Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain. Gene 159:245-248.
11. Bae SC, Yamaguchi-Iwai Y, Ogawa E, Maruyama M, Inuzuka M, Kagoshima H, Shigesada K, Satake M, Ito Y (1993): Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 8:809-814.
12. Balint E, Lapointe D, Drissi H, van der meijden C, Young DW, van Wijnen AJ, Stein JL, Stein GS, Lian JB (2003): Phenotype discovery by gene expression profiling: mapping of biological processes linked to BMP-2-mediated osteoblast differentiation. J Cell Biochem 89:401-426.
13. Banerjee C, Javed A, Choi J-Y, Green J, Rosen V, van Wijnen AJ, Stein JL, Lian JB, Stein GS (2001): Differential regulation of the two principal Runx2/Cbfa1 N-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology 142:4026-4039.
14. Banerjee C, McCabe LR, Choi J-Y, Hiebert SW, Stein JL, Stein GS, Lian JB (1997): Runt homology domain proteins in osteoblast differentiation: AML-3/ CBFA1 is a major component of a bone specific complex. J Cell Biochem 66:1-8.
15. Bangsow C, Rubins N, Glusman G, Bernstein Y, Negreanu V, Goldenberg D, Lotem J, Ben Asher E, Lancet D, Levanon D, Groner Y (2001): The RUNX3 gene-sequence, structure and regulated expression. Gene 279:221-232.
16. Barnes GL, Hebert KE, Javed A, Kamal MH, Einhorn TA, Lian JB, Stein GS, Gerstenfeld LC (2003a): Ectopic Runx2 regulates breast cancer metastasis associated osteolytic disease. J Bone Miner Res 18:S26(Abstract).
17. Barnes GL, Javed A, Waller SM, Kamal MH, Hebert KE, Hassan MQ, Bellahcene A, van Wijnen AJ, Young MF, Lian JB, Stein GS, Gerstenfeld LC (2003b): Osteoblast-related transcription factors Runx2 (Cbfa1/ AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res 63:2631-2637.
18. Barry FP, Boynton RE, Haynesworth S, Murphy JM, Zaia J (1999): The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun 265:134-139.
19. Berezney R, Mortillaro M, Ma H, Meng C, Samarabandu J, Wei X, Somanathan S, Liou WS, Pan SJ, Cheng PC (1996): Connecting nuclear architecture and genomic function. J Cell Biochem 62:223-226.
20. Bhakat KK, Izumi T, Yang SH, Hazra TK, Mitra S (2003): Role of acetylated human AP-endonuclease (APE1/ Ref-1) in regulation of the parathyroid hormone gene. EMBO J 22:6299-6309.
21. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B (1999): Sox9 is required for cartilage formation. Nat Genet 22:85-89.
22. Boskey AL, Wright TM, Blank RD (1999): Collagen and bone strength. J Bone Miner Res 14:330-335.
23. Bristow CA, Shore P (2003): Transcriptional regulation of the human MIP-lalpha promoter by RUNX1 and MOZ. Nucleic Acids Res 31:2735-2744.
24. Britos-Bray M, Friedman AD (1997): Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c-Myb. Mol Cell Biol 17:5127-5135.
25. Brubaker KD, Vessella RL, Brown LG, Corey E (2003): Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function. Prostate 56:13-22.
26. Bruhn L, Munnerlyn A, Grosschedl R (1997): ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function. Genes Dev 11:640-653.
27. Burns CE, DeBlasio T, Zhou Y, Zhang J, Zon L, Nimer SD (2002): Isolation and characterization of runxa and runxb, zebrafish members of the runt family of transcriptional regulators. Exp Hematol 30:1381-1389.
28. Byers BA, Pavlath GK, Murphy TJ, Karsenty G, Garcia AJ (2002): Cell-type-dependent up-regulation of in vitro mineralization after overexpression of the osteoblast-specific transcription factor Runx2/Cbfa1. J Bone Miner Res 17:1931-1944.
29. Cameron S, Taylor DS, TePas EC, Speck NA, Mathey-Prevot B (1994): Identification of a critical regulatory site in the human interleukin-3 promoter by in vivo footprinting. Blood 83:2851-2859.
30. Canalis E, Delany AM (2002): Mechanisms of glucocorticoid action in bone. Ann N Y Acad Sci 966:73-81.
31. Candeliere GA, Liu F, Aubin JE (2001): Individual osteoblasts in the developing calvaria express different gene repertoires. Bone 28:351-361.
32. Canon J, Banerjee U (2000): Runt and Lozenge function in Drosophila development. Semin Cell Dev Biol 11: 327-336.
33. Canon J, Banerjee U (2003): In vivo analysis of a developmental circuit for direct transcriptional activation and repression in the same cell by a Runx protein. Genes Dev 17:838-843.
34. Capco DG, Wan KM, Penman S (1982): The nuclear matrix: three-dimensional architecture and protein composition. Cell 29:847-858.
35. Chambers TJ (2000): Regulation of the differentiation and function of osteoclasts. J Pathol 192:4-13.
36. Chang DJ, Ji C, Kim KK, Casinghino S, McCarthy TL, Centrella M (1998): Reduction in transforming growth factor beta receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid. J Biol Chem 273:4892-4896.
37. Chang L, Karin M (2001): Mammalian MAP kinase signalling cascades. Nature 410:37-40.
38. Chen D, Ji X, Harris MA, Feng JQ, Karsenty G, Celeste AJ, Rosen V, Mundy GR, Harris SE (1998): Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 142:295-305.
39. Chen G, Fernandez J, Mische S, Courey AJ (1999): A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development. Genes Dev 13:2218-2230.
40. Chen HL, Demiralp B, Schneider A, Koh AJ, Silve C, Wang CY, McCauley LK (2002a): Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells. J Biol Chem 277:19374-19381.
41. Chen S, Gu TT, Sreenath T, Kulkarni AB, Karsenty G, MacDougall M (2002b): Spatial expression of Cbfa1/ Runx2 isoforms in teeth and characterization of binding sites in the DSPP gene. Connect Tissue Res 43: 338-344.
42. Cheng B, Kato Y, Zhao S, Luo J, Sprague E, Bonewald LF, Jiang JX (2001): PGE(2) is essential for gap junction-mediated intercellular communication between osteocyte-like MLO-Y4 cells in response to mechanical strain. Endocrinology 142:3464-3473.
43. Cheng SL, Shao JS, Charlton-Kachigian N, Loewy AP, Towler DA (2003): Msx2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem
44. Chikazu D, Li X, Kawaguchi H, Sakuma Y, Voznesensky OS, Adams DJ, Xu M, Hoshio K, Katavic V, Herschman HR, Raisz LG, Pilbeam CC (2002): Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfa1 binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. J Bone Miner Res 17:1430-1440.
45. Choi CH, Hiromura M, Usheva A (2003): Transcription factor IIB acetylates itself to regulate transcription. Nature 424:965-969.
46. Choi J-Y, Pratap J, Javed A, Zaidi SK, van Wijnen AJ, Lian JB, Stein JL, Jones SN, Stein GS (2000): In vivo replacement of the Runx2/Cbfa1 gene with a mutant gene lacking a subnuclear targeting signal and transcriptional regulatory functions results in severe skeletal abnormalities. J Bone Miner Res 15:S157(Abstract).
47. Choi J-Y, Pratap J, Javed A, Zaidi SK, Xing L, Balint E, Dalamangas S, Boyce B, van Wijnen AJ, Lian JB, Stein JL, Jones SN, Stein GS (2001): Subnudear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc Natl Acad Sci U S A 98:8650-8655.
48. Choi KY, Lee SW, Park MH, Bae YC, Shin HI, Nam S, Kim YJ, Kim HJ, Ryoo HM (2002): Spatio-temporal expression patterns of Runx2 isoforms in early skeletogenesis. Exp Mol Med 34:426-433.
49. Church VL, Francis-West P (2002): Wnt signalling during limb development. Int J Dev Biol 46:927-936.
50. Cobourne MT, Sharpe PT (2003): Tooth and jaw: molecular mechanisms of patterning in the first branchial arch. Arch Oral Biol 48:1-14.
51. Crosier PS, Kalev-Zylinska ML, Hall CJ, Flores MV, Horsfield JA, Crosier KE (2002): Pathways in blood and vessel development revealed through zebrafish genetics. Int J Dev Biol 46:493-502.
52. Cui CB, Cooper LF, Yang X, Karsenty G, Aukhil I (2003): Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Mol Cell Biol 23:1004-1013.
53. D'Alonzo RC, Selvamurugan N, Karsenty G, Partridge NC (2002): Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation. J Biol Chem 277:816-822.
54. Damsky CH (1999): Extracellular matrix-integrin interactions in osteoblast function and tissue remodeling. Bone 25:95-96.
55. de Crombrugghe B, Lefebvre V, Behringer RR, Bi W, Murakami S, Huang W (2000): Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol 19:389-394.
56. de Crombrugghe B, Lefebvre V, Nakashima K (2001): Regulatory mechanisms in the pathways of cartilage and bone formation. Curr Opin Cell Biol 13:721-727.
57. Drissi H, Luc Q, Shakoori R, Chuva de Sousa Lopes S, Choi J-Y, Terry A, Hu M, Jones S, Neil JC, Lian JB, Stein JL, van Wijnen AJ, Stein GS (2000): Transcriptional autoregulation of the bone related CBFA1/ RUNX2 gene. J Cell Physiol 184:341-350.
58. 2Vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Exp Cell Res 274:323-333.
59. Drissi H, Pouliot A, Stein JL, van Wijnen AJ, Stein GS, Lian JB (2002b): Identification of novel protein/DNA interactions within the promoter of the bone-related transcription factor Runx2/Cbfa1. J Cell Biochem 86:403-412.
60. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G (1997): Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747-754.
61. Duffy JB, Gergen JP (1991): The Drosophila segmentation gene runt acts as a position-specific numerator element necessary for the uniform expression of the sex-determining gene Sex-lethal. Genes Dev 5:2176-2187.
62. Duffy JB, Kania MA, Gergen JP (1991): Expression and function of the Drosophila gene runt in early stages of neural development. Development 113:1223-1230.
63. Dworetzky SI, Wright KL, Fey EG, Penman S, Lian JB, Stein JL, Stein GS (1992): Sequence-specific DNA-binding proteins are components of a nuclear matrix-attachment site. Proc Natl Acad Sci U S A 89:4178-4182.
64. Enomoto H, Enomoto-Iwamoto M, Iwamoto M, Nomura S, Himeno M, Kitamura Y, Kishimoto T, Komori T (2000): Cbfa1 is a positive regulatory factor in chondrocyte maturation. J Biol Chem 275:8695-8702.
65. Enomoto H, Shiojiri S, Hoshi K, Furuichi T, Fukuyama R, Yoshida CA, Kanatani N, Nakamura R, Mizuno A, Zanma A, Yano K, Yasuda H, Higashio K, Takada K, Komori T (2003): Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene. J Biol Chem 278:23971-23977.
66. Ferrari D, Kosher RA (2002): Dlx5 is a positive regulator of chondrocyte differentiation during endochondral ossification. Dev Biol 252:257-270.
67. Ferrigno O, Lallemand F, Verrecchia F, L'Hoste S, Camonis J, Atfi A, Mauviel A (2002): Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling. Oncogene 21:4879-4884.
68. Fisher AL, Ohsako S, Caudy M (1996): The WRPW motif of the hairy-related basic helix-loop-helix repressor proteins acts as a 4-amino-acid transcription repression and protein-protein interaction domain. Mol Cell Biol 16:2670-2677.
69. Franceschi RT, Xiao G (2003): Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J Cell Biochem 88:446-454.
70. Frenkel B, Montecino M, Green J, Aslam F, Desai R, Banerjee C, Stein JL, Lian JB, Stein GS (1996): Basal and vitamin D-responsive activity of the rat osteocalcin promoter in stably transfected osteosarcoma cells: requirement of upstream sequences for control by the proximal regulatory domain. Endocrinology 137:1080-1088.
71. Fu M, Rao M, Wang C, Sakamaki T, Wang J, Di Vizio D, Zhang X, Albanese C, Balk S, Chang C, Fan S, Rosen E, Palvimo JJ, Janne OA, Muratoglu S, Avantaggiati ML, Pestell RG (2003): Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Mol Cell Biol 23:8563-8575.
72. Furlan F, Lecanda F, Screen J, Civitelli R (2001): Proliferation, differentiation and apoptosis in connexin43-null osteoblasts. Cell Commun Adhes 8:367-371.
73. Galindo M, Stein JL, Lian JB, Stein GS, van Wijnen AJ (2003): Bone-specific Runx2 levels are tightly regulated during the cell cycle to support a novel function in control of the switch from proliferation to quiescence in osteoblasts. J Bone Miner Res. (Manuscript submitted.)
74. Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P (2002): High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Mol Cell Biol 22:6222-6233.
75. Ghozi MC, Bernstein Y, Negreanu V, Levanon D, Groner Y (1996): Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions. Proc Natl Acad Sci U S A 93:1935-1940.
76. Giese K, Kingsley C, Kirshner JR, Grosschedl R (1995): Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev 9:995-1008.
77. Gilbert L, He X, Farmer P, Boden S, Kozlowski M, Rubin J, Nanes MS (2000): Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141:3956-3964.
78. Gilbert L, He X, Farmer P, Rubin J, Drissi H, van Wijnen AJ, Lian JB, Stein GS, Nanes MS (2002): Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/ AML3/PEBP2αA) is inhibited by tumor necrosis factor-α. J Biol Chem 277:2695-2701.
79. Glimcher MJ (1989): Mechanism of calcification: role of collagen fibrils and collagen-phosphoprotein complexes in vitro and in vivo. Anat Rec 224:139-153.
80. Goel A, Janknecht R (2003): Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu. Mol Cell Biol 23:6243-6254.
81. Golling G, Li L, Pepling M, Stebbins M, Gergen JP (1996): Drosophila homologs of the proto-oncogene product PEBP2/CBF beta regulate the DNA-binding properties of Runt. Mol Cell Biol 16:932-942.
82. Gori F, Thomas T, Hicok KC, Spelsberg TC, Riggs BL (1999): Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res 14:1522-1535.
83. Gripp KW, Zackai EH, Stolle CA (2000): Mutations in the human TWIST gene. Hum Mutat 15:150-155.
84. Gronthos S, Graves SE, Ohta S, Simmons PJ (1994): The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 84:4164-4173.
85. Gruda MC, van Amsterdam J, Rizzo CA, Durham SK, Lira S, Bravo R (1996): Expression of FosB during mouse development: normal development of FosB knockout mice. Oncogene 12:2177-2185.
86. Guo B, Odgren PR, van Wijnen AJ, Last TJ, Nickerson J, Penman S, Lian JB, Stein JL, Stein GS (1995): The nuclear matrix protein NMP-1 is the transcription factor YY1. Proc Natl Acad Sci U S A 92:10526-10530.
87. Guo WH, Weng LQ, Ito K, Chen LF, Nakanishi H, Tatematsu M, Ito Y (2002): Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. Oncogene 21:8351-8355.
88. Gutierrez J, Sierra J, Medina R, Puchi M, Imschenetzky M, Hiebert S, van Wijnen A, Lian JB, Stein G, Stein J, Montecino M (2000a): Interaction of CBFα/AML/ PEBP2α transcription factors with nudeosomal sequences requires flexibility in the translational positioning of the histone octamer and exposure of the Cbfα site. Biochemistry 39:13565-13574.
89. Gutierrez S, Javed A, Tennant D, van Rees M, Montecino M, Stein GS, Stein JL, Lian JB (2002): CCAAT/ enhancer-binding proteins (C/EBP) β and δ activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J Biol Chem 277:1316-1323.
90. Gutierrez S, Javed A, Tennant D, van Rees M, van Wijnen AJ, Stein JL, Stein GS, Lian JB (2000b): C/EBP is a potent activator of osteocalcin gene transcription. J Bone Miner Res 15:S497(Abstract).
91. Hallberg B, Thornell A, Holm M, Grundstrom T (1992): SEF1 binding is important for T cell specific enhancers of genes for T cell receptor-CD3 subunits. Nucleic Acids Res 20:6495-6499.
92. Hanai J, Chen LF, Kanno T, Ohtani-Fujita N, Kim WY, Guo WH, Imamura T, Ishidou Y, Fukuchi M, Shi MJ, Stavnezer J, Kawabata M, Miyazono K, Ito Y (1999): Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha: promoter. J Biol Chem 274:31577-31582.
93. Harada H, Tagashira S, Fujiwara M, Ogawa S, Katsumata T, Yamaguchi A, Komori T, Nakatsuka M (1999): Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 274:6972-6978.
94. Harris SA, Zhang M, Kidder LS, Evans GL, Spelsberg TC, Turner RT (2000): Effects of orbital spaceflight on human osteoblastic cell physiology and gene expression. Bone 26:325-331.
95. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW (1998): The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13:325-349.
96. Hay E, Lemonnier J, Fromigue O, Marie PJ (2001): Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem 276:29028-29036.
97. Heino J (2000): The collagen receptor integrins have distinct ligand recognition and signaling functions. Matrix Biol 19:319-323.
98. Hess J, Porte D, Munz C, Angel P (2001): AP-1 and Cbfa/ Runt physically interact and regulate PTH-dependent MMP13 expression in osteoblasts through a new OSE2/ AP-1 composite element. J Biol Chem 276:20029-20038.
99. Hiebert SW, Lutterbach B, Amann J (2001): Role of co-repressors in transcriptional repression mediated by the t(8;21), t(16;21), t(12;21), and inv(16) fusion proteins. Curr Opin Hematol 8:197-200.
100. Himeno M, Enomoto H, Liu W, Ishizeki K, Nomura S, Kitamura Y, Komori T (2002): Impaired vascular invasion of Cbfa1-deficient cartilage engrafted in the spleen. J Bone Miner Res 17:1297-1305.
101. Hoffmann HM, Catron KM, van Wijnen AJ, McCabe LR, Lian JB, Stein GS, Stein JL (1994): Transcriptional control of the tissue-specific, developmentally regulated osteocalcin gene requires a binding motif for the Msx family of homeodomain proteins. Proc Natl Acad Sci U S A 91:12887-12891.
102. Holleville N, Quilhac A, Bontoux M, Monsoro-Burq AH (2003): BMP signals regulate Dlx5 during early avian skull development. Dev Biol 257:177-189.
103. Ignelzi MA Jr, Wang W, Young AT (2003): Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures. J Bone Miner Res 18: 751-759.
104. Inada M, Yasui T, Nomura S, Miyake S, Deguchi K, Himeno M, Sato M, Yamagiwa H, Kimura T, Yasui N, Ochi T, Endo N, Kitamura Y, Kishimoto T, Komori T (1999): Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn 214:279-290.
105. Inoue K, Ozaki S, Shiga T, Ito K, Masuda T, Okado N, Iseda T, Kawaguchi S, Ogawa M, Bae SC, Yamashita N, Itohara S, Kudo N, Ito Y (2002): Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat Neurosci 5:946-954.
106. Ito Y, Miyazono K (2003): RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr Opin Genet Dev 13:43-47.
107. Jabs EW, Muller U, Li X, Ma L, Luo W, Haworth IS, Klisak I, Sparkes R, Warman ML, Mulliken JB, Snead ML, Maxson R (1993): A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 75:443-450.
108. Jackson ME, Shalhoub V, Lian JB, Stein GS, Marks SC Jr (1994): Aberrant gene expression in cultured mammalian bone cells demonstrates an osteoblast defect in osteopetrosis. J Cell Biochem 55:366-372.
109. Javed A, Barnes GL, Jassanya BO, Stein JL, Gerstenfeld L, Lian JB, Stein GS (2001): runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins. Mol Cell Biol 21:2891-2905.
110. Javed A, Guo B, Hiebert S, Choi J-Y, Green J, Zhao S-C, Osborne MA, Stifani S, Stein JL, Lian JB, van Wijnen AJ, Stein GS (2000): Groucho/TLE/R-Esp proteins associate with the nuclear matrix and repress RUNX (CBFα /AML/PEBP2α) dependent activation of tissue-specific gene transcription. J Cell Sci 113:2221-2231.
111. Javed A, Gutierrez S, Montecino M, van Wijnen AJ, Stein JL, Stein GS, Lian JB (1999): Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D responsive transcription and contribute to chromatin organization. Mol Cell Biol 19:7491-7500.
112. Jeon MJ, Kim JA, Kwon SH, Kim SW, Park KS, Park SW, Kim SY, Shin CS (2003): Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts. J Biol Chem 278:23270-23277.
113. Ji C, Casinghino S, Chang DJ, Chen Y, Javed A, Ito Y, Hiebert SW, Lian JB, Stein GS, McCarthy TL, Centrella M (1998): CBFa (AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation. J Cell Biochem 69:353-363.
114. Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC (1998): Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res 13:793-802.
115. Jimenez MJ, Balbin M, Lopez JM, Alvarez J, Komori T, Lopez-Otin C (1999): Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol Cell Biol 19:4431-4442.
116. Jochum W, Passegue E, Wagner EF (2001): AP-1 in mouse development and tumorigenesis. Oncogene 20: 2401-2412.
117. Johannsen E, Koh E, Mosialos G, Tong X, Kieff E, Grossman SR (1995): Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. J Virol 69:253-262.
118. Kagoshima H, Akamatsu Y, Ito Y, Shigesada K (1996): Functional dissection of the alpha and beta subunits of transcription factor PEBP2 and the redox susceptibility of its DNA binding activity. J Biol Chem 271:33074-33082.
119. Kahler RA, Westendorf JJ (2003): Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter. J Biol Chem 278:11937-11944.
120. Kamachi Y, Ogawa E, Asano M, Ishida S, Murakami Y, Satake M, Ito Y, Shigesada K (1990): Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J Virol 64:4808-4819.
121. Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, Donowitz M, Hisaminato A, Fujiwara T, Ito Y, Cantley LC, Yaffe MB (2000): TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J 19:6778-6791.
122. Kania MA, Bonner AS, Duffy JB, Gergen JP (1990): The Drosophila segmentation gene runt encodes a novel nuclear regulatory protein that is also expressed in the developing nervous system. Genes Dev 4:1701-1713.
123. Kaplan FS, Shore EM (2000): Progressive osseous heteroplasia. J Bone Miner Res 15:2084-2094.
124. Karsdal MA, Larsen L, Engsig MT, Lou H, Ferreras M, Lochter A, Delaisse JM, Foged NT (2002): Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J Biol Chem 277:44061-44067.
125. Kataoka H, Ochi M, Enomoto K, Yamaguchi A (2000): Cloning and embryonic expression patterns of the zebrafish Runt domain genes, runxa and runxb. Mech Dev 98:139-143.
126. Kato N, Tamura G, Fukase M, Shibuya H, Motoyama T (2003): Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants. Am J Pathol 163:387-391.
127. Kern B, Shen J, Starbuck M, Karsenty G (2001): Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. J Biol Chem 276:7101-7107.
128. Kim HJ, Kim JH, Bae SC, Choi JY, Kim HJ, Ryoo HM (2003a): The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem 278:319-326.
129. Kim HJ, Lee MH, Park HS, Park MH, Lee SW, Kim SY, Choi JY, Shin HI, Kim HJ, Ryoo HM (2003b): Erk pathway and activator protein 1 play crucial roles in FGF2-stimulated premature cranial suture closure. Dev Dyn 227:335-346.
130. Kim S, Koga T, Isobe M, Kern BE, Yokochi T, Chin YE, Karsenty G, Taniguchi T, Takayanagi H (2003c): Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev 17:1979-1991.
131. Kim WY, Sieweke M, Ogawa E, Wee HJ, Englmeier U, Graf T, Ito Y (1999): Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains. EMBO J 18:1609-1620.
132. Kitabayashi I, Yokoyama A, Shimizu K, Ohki M (1998): Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J 17:2994-3004.
133. Kiyoshima T, Yamauchi M, Wong C, Jheon A, Ganss B, Sodek J (2002): An L1 element disrupts human bone sialoprotein promoter: lack of tissue-specific regulation by distalless5 (Dlx5) and runt homeodomain protein2 (Runx2)/core binding factor a1 (Cbfa1) elements. Gene 299:205-217.
134. Klampfer L, Zhang J, Zelenetz AO, Uchida H, Nimer SD (1996): The AML1/ ETO fusion protein activates transcription of BCL-2. Proc Natl Acad Sci U S A 93: 14059-14064.
135. Kobayashi H, Gao Y, Ueta C, Yamaguchi A, Komori T (2000): Multilineage differentiation of Cbfa1-deficient calvarial cells in vitro. Biochem Biophys Res Commun 273:630-636.
136. Komori T (2002): Runx2, a multifunctional transcription factor in skeletal development. J Cell Biochem 87:1-8.
137. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao Y-H, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T (1997): Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
138. Kowenz-Leutz E, Leutz A (1999): A C/EBP beta isoform recruits the SWI/ SNF complex to activate myeloid genes. Mol Cell 4:735-743.
139. Kundu M, Javed A, Jeon JP, Horner A, Shum L, Eckhaus M, Muenke M, Lian JB, Yang Y, Nuckolls GH, Stein GS, Liu PP (2002): Cbfbeta interacts with Runx2 and has a critical role in bone development. Nat Genet 32: 639-644.
140. Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL (2002): Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 143:2376-2384.
141. Lee B, Thirunavukkarasu K, Zhou L, Pastore L, Baldini A, Hecht J, Geoffroy V, Ducy P, Karsenty G (1997): Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in deidocranial dysplasia. Nat Genet 16:307-310.
142. Lee KS, Hong SH, Bae SC (2002): Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene 21:7156-7163.
143. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM, Bae SC (2000): Runx2 is a common target of transforming growth factor betal and bone morphogenetic protein 2, and cooperation between runx2 and smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20:8783-8792.
144. Lee MH, Javed A, Kim HJ, Shin HI, Gutierrez S, Choi JY, Rosen V, Stein JL, van Wijnen AJ, Stein GS, Lian JB, Ryoo HM (1999a): Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor β1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem 73:114-125.
145. Lee MH, Kim YJ, Kim HJ, Park HD, Kang AR, Kyung HM, Sung JH, Wozney JM, Kim HJ, Ryoo HM (2003a): BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 278:34387-34394.
146. Lee MH, Kwon TG, Park HS, Wozney JM, Ryoo HM (2003b): BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun 309:689-694.
147. Lee MS, Lowe GN, Strong DD, Wergedal JE, Glackin CA (1999b): TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. J Cell Biochem 75:566-577.
148. Lee SW, Tsou A-P, Chan H, Thomas J, Petrie K, Eugui EM, Allison AC (1988): Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin 1β mRNA. Proc Natl Acad Sci U S A 85:1204-1208.
149. Lefebvre V, Behringer RR, de Crombrugghe B (2001): L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage 9 Suppl A:S69-S75.
150. Lengner C, Drissi H, Choi J, van Wijnen AJ, Stein JL, Stein GS, Lian JB (2001): The bone related Runx-2/Cbfa-1 promoter mediates restricted expression in mesenchymal condensations and chondrocytes. J Bone Miner Res 16:S366(Abstract).
151. Lengner CJ, Drissi H, Choi J-Y, van Wijnen AJ, Stein JL, Stein GS, Lian JB (2002): Activation of the bone related Runx2/Cbfa1 promoter in mesenchymal condensations and developing chondrocytes of the axial skeleton. Mech Dev 114:167-170.
152. Lengner CJ, Lepper C, van Wijnen AJ, Stein JL, Lian JB, Stein GS (2003): Mechanisms regulating Runx 1 and 2 gene expression during mesenchymal chondrogenesis. J Bone Miner Res 18:S61(Abstract).
153. Levanon D, Bernstein Y, Negreanu V, Ghozi MC, Bar-Am I, Aloya R, Goldenberg D, Lotem J, Groner Y (1996): A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1. DNA Cell Biol 15:175-185.
154. Levanon D, Bettoun D, Harris-Cerruti C, Woolf E, Negreanu V, Eilam R, Bernstein Y, Goldenberg D, Xiao C, Fliegauf M, Kremer E, Otto F, Brenner O, Lev-Tov A, Groner Y (2002): The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J 21:3454-3463.
155. Levanon D, Brenner O, Negreanu V, Bettoun D, Woolf E, Eilam R, Lotem J, Gat U, Otto F, Speck N, Groner Y (2001): Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis. Mech Dev 109:413-417.
156. Levanon D, Goldstein RE, Bernstein Y, Tang H, Goldenberg D, Stifani S, Paroush Z, Groner Y (1998): Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc Natl Acad Sci U S A 95:11590-11595.
157. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, Groner Y (1994): AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23:425-432.
158. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y (2002): Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109: 113-124.
159. Lian JB, Balint E, Javed A, Drissi H, Vitti R, Quinlan EJ, Zhang L, van Wijnen AJ, Stein JL, Speck N, Stein GS (2003): Runx1/AML1 hematopoietic transcription factor contributes to skeletal development in vivo. J Cell Physiol 196:301-311.
160. Lian JB, Stein GS (1995): Development of the osteoblast phenotype: molecular mechanisms mediating osteoblast growth and differentiation. Iowa Orthop J 15:118-140.
161. Liang X, Lu Y, Wilkes M, Neubert TA, Resh MD (2004): The N-terminal SH4 region of the Src family kinase Fyn is modified by methylation and heterogeneous fatty acylation: role in membrane targeting, cell adhesion and spreading. J Biol Chem 279:8133-8139.
162. Libermann TA, Pan Z, Akbarali Y, Hetherington CJ, Boltax J, Yergeau DA, Zhang DE (1999): AML1 (CBFa1pha2) cooperates with B cell-specific activating protein (BSAP/ PAX5) in activation of the B cell-specific BLK gene promoter. J Biol Chem 274:24671-24676.
163. Linggi B, Muller-Tidow C, van de LL, Hu M, Nip J, Serve H, Berdel WE, van der RB, Quelle DE, Rowley JD, Cleveland J, Jansen JH, Pandolfi PP, Hiebert SW (2002): The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Nat Med 8:743-750.
164. Liu W, Toyosawa S, Furuichi T, Kanatani N, Yoshida C, Liu Y, Himeno M, Narai S, Yamaguchi A, Komori T (2001): Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol 155:157-166.
165. Liu YH, Kundu R, Wu L, Luo W, Ignelzi MAJr, Snead ML, Maxson RE Jr (1995): Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull. Proc Natl Acad Sci U S A 92:6137-6141.
166. Locklin RM, Khosla S, Turner RT, Riggs BL (2003): Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone. J Cell Biochem 89:180-190.
167. Lutterbach B, Hiebert SW (2000): Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation. Gene 245:223-235.
168. Lutterbach B, Sun D, Schuetz J, Hiebert SW (1998): The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein. Mol Cell Biol 18:3604-3611.
169. Lutterbach B, Westendorf JJ, Linggi B, Isaac S, Seto E, Hiebert SW (2000): A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. J Biol Chem 275:651-656.
170. Lynch M, Capparelli C, Stein JL, Stein GS, Lian JB (1998): Apoptosis during bone-like tissue development in vitro. J Cell Biochem 68:31-49.
171. Lynch MP, Stein JL, Stein GS, Lian JB (1995): The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp Cell Res 216:35-45.
172. Mancini MA, Shan B, Nickerson JA, Penman S, Lee W-H (1994): The retinoblastoma gene product is a cell cycle-dependent, nuclear matrix-associated protein. Proc Natl Acad Sci U S A 91:418-422.
173. Manolagas SC, Kousteni S, Jilka RL (2002): Sex steroids and bone. Recent Prog Horm Res 57:385-409.
174. Mao S, Frank RC, Zhang J, Miyazaki Y, Nimer SD (1999): Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias. Mol Cell Biol 19:3635-3644.
175. Marie PJ, Debiais F, Hay E (2002): Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling. Histol Histopathol 17:877-885.
176. Marks SCJr, Mackowiak S, Shalhoub V, Lian JB, Stein GS (1989): Proliferation and differentiation of osteoblasts in osteopetrotic rats: modification in expression of genes encoding cell growth and extracellular matrix proteins. Conn Tissue Res 21:107-113; discussion 114-116.
177. Martensson A, Xie XQ, Persson C, Holm M, Grundstrom T, Martensson IL (2001): PEBP2 and c-myb sites crucial for lambda5 core enhancer activity in pre-B cells. Eur J Immunol 31:3165-3174.
178. Marzia M, Sims NA, Voit S, Migliaccio S, Taranta A, Bernardini S, Faraggiana T, Yoneda T, Mundy GR, Boyce BF, Baron R, Teti A (2000): Decreased c-Src expression enhances osteoblast differentiation and bone formation. J Cell Biol 151:311-320.
179. Massague J (1998): TGF-beta signal transduction. Annu Rev Biochem 67:753-791.
180. McCabe LR, Banerjee C, Kundu R, Harrison RJ, Dobner PR, Stein JL, Lian JB, Stein GS (1996): Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of fra-2 and jun D during differentiation. Endocrinology 137:4398-4408.
181. McCarthy TL, Centrella M (2001): Local IGF-I expression and bone formation. Growth Horm IGF Res 11: 213-219.
182. McCarthy TL, Chang WZ, Liu Y, Centrella M (2003): Runx2 integrates estrogen activity in osteoblasts. J Biol Chem 278:43121-43129.
183. McCarthy TL, Ji C, Chen Y, Kim KK, Imagawa M, Ito Y, Centrella M (2000): Runt domain factor (Runx)-dependent effects on CCAAT/ enhancer-binding protein delta expression and activity in osteoblasts. J Biol Chem 275:21746-21753.
184. McCauley LK, Koh-Paige AJ, Chen H, Chen C, Ontiveros C, Irwin R, McCabe LR (2001): Parathyroid hormone stimulates fra-2 expression in osteoblastic cells in vitro and in vivo. Endocrinology 142:1975-1981.
185. McLarren KW, Lo R, Grbavec D, Thirunavukkarasu K, Karsenty G, Stifani S (2000): The mammalian basic helix loop helix protein HES-1 binds to and modulates the transactivating function of the runt-related factor cbfa1. J Biol Chem 275:530-538.
186. McLean TW, Ringold S, Neuberg D, Stegmaier K, Tantravahi R, Ritz J, Koeffler HP, Takeuchi S, Janssen JW, Seriu T, Bartram CR, Sallan SE, Gilliland DG, Golub TR (1996): TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood 88:4252-4258.
187. McNeil S, Zeng C, Harrington KS, Hiebert S, Lian JB, Stein JL, van Wijnen AJ, Stein GS (1999): The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/ CBFalpha2 transcription factor. Proc Natl Acad Sci U S A 96:14882-14887.
188. Merriman HL, van Wijnen AJ, Hiebert S, Bidwell JP, Fey E, Lian J, Stein J, Stein GS (1995): The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter. Biochemistry 34:13125-13132.
189. Meyers S, Hiebert SW (2000): Alterations in subnuclear trafficking of nuclear regulatory factors in acute leukemia. J Cell Biochem 35:93-98.
190. Meyers S, Lenny N, Hiebert SW (1995): The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol Cell Biol 15:1974-1982.
191. Meyers S, Lenny N, Sun W-H, Hiebert SW (1996): AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Oncogene 13:303-312.
192. Miller J, Horner A, Stacy T, Lowrey C, Lian JB, Stein G, Nuckolls GH, Speck NA (2002): The core-binding factor beta subunit is required for bone formation and hematopoietic maturation. Nat Genet 32:645-649.
193. Milona MA, Gough JE, Edgar AJ (2003): Expression of alternatively spliced isoforms of human Sp7 in osteoblast-like cells. BMC Genomics 4:43.
194. Mink S, Haenig B, Klempnauer KH (1997): Interaction and functional collaboration of p300 and C/EBPbeta. Mol Cell Biol 17:6609-6617.
195. Miyoshi H, Ohira M, Shimizu K, Mitani K, Hirai H, Imai T, Yokoyama K, Soeda E, Ohki M (1995): Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res 23:2762-2769.
196. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M (1991): t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci U S A 88:10431-10434.
197. Montecino M, Lian J, Stein G, Stein J (1996): Changes in chromatin structure support constitutive and developmentally regulated transcription of the bone-specific osteocalcin gene in osteoblastic cells. Biochemistry 35:5093-5102.
198. Montecino M, Pockwinse S, Lian J, Stein G, Stein J (1994): DNase I hypersensitive sites in promoter elements associated with basal and vitamin D dependent transcription of the bone-specific osteocalcin gene. Biochemistry 33:348-353.
199. Mueller E, Drori S, Aiyer A, Yie J, Sarraf P, Chen H, Hauser S, Rosen ED, Ge K, Roeder RG, Spiegelman BM (2002): Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms. J Biol Chem 277:41925-41930.
200. Mundlos S (1999): Cleidocranial dysplasia: clinical and molecular genetics. J Med Genet 36:177-182.
201. Mundlos S, Mulliken JB, Abramson DL, Warman ML, Knoll JH, Olsen BR (1995): Genetic mapping of cleidocranial dysplasia and evidence of a microdeletion in one family. Hum Mol Genet 4:71-75.
202. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JHM, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR (1997): Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89:773-779.
203. Murtaugh LC, Zeng L, Chyung JH, Lassar AB (2001): The chick transcriptional repressor Nkx3.2 acts downstream of Shh to promote BMP-dependent axial chondrogenesis. Dev Cell 1:411-422.
204. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B (2002): The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29.
205. Niki M, Okada H, Takano H, Kuno J, Tani K, Hibino H, Asano S, Ito Y, Satake M, Noda T (1997): Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor. Proc Natl Acad Sci U S A 94:5697-5702.
206. Ning YM, Robins DM (1999): AML3/Cbfalpha1 is required for androgen-specific activation of the enhancer of the mouse sex-limited protein (Slp) gene. J Biol Chem 274:30624-30630.
207. Noble BS, Peet N, Stevens HY, Brabbs A, Mosley JR, Reilly GC, Reeve J, Skerry TM, Lanyon LE (2003): Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone. Am J Physiol Cell Physiol 284:C934-C943
208. North T, Gu TL, Stacy T, Wang Q, Howard L, Binder M, Marin-Padilla M, Speck NA (1999): Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development 126:2563-2575.
209. Nuchprayoon I, Meyers S, Scott LM, Suzow J, Hiebert SW, Friedman AD (1994): PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2β/ CBFβ proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol Cell Biol 14:5558-5568.
210. Nucifora G, Birn DJ, Espinosa RI, Erickson P, LeBeau MM, Roulston D, McKeithan TW, Drabkin H, Rowley JD (1993): Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. Blood 81:2728-2734.
211. Nucifora G, Rowley JD (1995): AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86:1-14.
212. Nuthall HN, Joachim K, Palaparti A, Stifani S (2002): A role for cell cycle-regulated phosphorylation in Groucho-mediated transcriptional repression. J Biol Chem 277:51049-51057.
213. O'Brien CA, Kern B, Gubrij I, Karsenty G, Manolagas SC (2002): Cbfa1 does not regulate RANKL gene activity in stromal/osteoblastic cells. Bone 30:453-462.
214. Oelgeschlager M, Janknecht R, Krieg J, Schreek S, Luscher B (1996): Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M. EMBO J 15: 2771-2780.
215. Ogawa E, Inuzuka M, Maruyama M, Satake M, Naito-Fujimoto M, Ito Y, Shigesada K (1993a): Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α. Virology 194:314-331.
216. Ogawa E, Maruyama M, Kagoshima H, Inuzuka M, Lu J, Satake M, Shigesada K, Ito Y (1993b): PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc Natl Acad Sci U S A 90: 6859-6863.
217. Ogawa S, Harada H, Fujiwara M, Tagashira S, Katsumata T, Takada H (2000): Cbfa1, an essential transcription factor for bone formation, is expressed in testis from the same promoter used in bone. DNA Res 7:181-185.
218. Ogihara H, Kanno T, Morii E, Kim DK, Lee YM, Sato M, Kim WY, Nomura S, Ito Y, Kitamura Y (1999): Synergy of PEBP2/CBF with mi transcription factor (MITF) for transactivation of mouse mast cell protease 6 gene. Oncogene 18:4632-4639.
219. Okuda T, Cai Z, Yang S, Lenny N, Lyu CJ, van Deursen JM, Harada H, Downing JR (1998): Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Blood 91:3134-3143.
220. Okuda T, Takeda K, Fujita Y, Nishimura M, Yagyu S, Yoshida M, Akira S, Downing JR, Abe T (2000): Biological characteristics of the leukemia-associated transcriptional factor AML1 disclosed by hematopoietic rescue of AML1-deficient embryonic stem cells by using a knock-in strategy. Mol Cell Biol 20: 319-328.
221. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR (1996): AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321-330.
222. Otto F, Stock M, Fliegauf M, Fenaux P, Preudhomme C, Lubbert M (2003): Absence of somatic mutations within the Runt domain of AML2/RUNX3 in acute myeloid leukaemia. Leukemia 17:1677-1678.
223. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GWH, Beddington RSP, Mundlos S, Olsen BR, Selby PB, Owen MJ (1997): Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
224. Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS, Lian JB (1991): Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 128: 1496-1504.
225. Pardali E, Xie XQ, Tsapogas P, Itoh S, Arvanitidis K, Heldin CH, ten Dijke P, Grundstrom T, Sideras P (2000): Smad and AML proteins synergistically confer transforming growth factor beta1 responsiveness to human germ-line IgA genes. J Biol Chem 275:3552-3560.
226. Paredes R, Arriagada G, Cruzat F, Villagra A, Olate J, Zaidi SK, van Wijnen AJ, Lian J, Stein G, Stein J, Montecino M (2004): The Runx2 transcription factor interacts with the 1α,25-dihydroxy vitamin D3 receptor and facilitates 1α,25-dihydroxy vitamin D3-dependent upregulation of the rat OC gene expression in osteoblastic cells. Manuscript submitted.
227. Paredes R, Gutierrez J, Gutierrez S, Allison L, Puchi M, Imschenetzky M, van Wijnen A, Lian J, Stein G, Stein J, Montecino M (2002): Interaction of the 1alpha,25-dihydroxyvitamin D3 receptor at the distal promoter region of the bone-specific osteocalcin gene requires nucleosomal remodelling. Biochem J 363:667-676.
228. Parfitt AM (2002): Parathyroid hormone and periosteal bone expansion. J Bone Miner Res 17:1741-1743.
229. Park JH, Park BH, Kim HK, Park TS, Baek HS (2002): Hypoxia decreases Runx2/Cbfa1 expression in human osteoblast-like cells. Mol Cell Endocrinol 192:197-203.
230. Park MH, Shin HI, Choi JY, Nam SH, Kim YJ, Kim HJ, Ryoo HM (2001): Differential expression patterns of Runx2 isoforms in cranial suture morphogenesis. J Bone Miner Res 16:885-892.
231. Pelletier N, Champagne N, Stifani S, Yang XJ (2002): MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2. Oncogene 21:2729-2740.
232. Perry C, Eldor A, Soreq H (2002): Runx1/AML1 in leukemia: disrupted association with diverse protein partners. Leuk Res 26:221-228.
233. Petrovick MS, Hiebert SW, Friedman AD, Hetherington CJ, Tenen DG, Zhang DE (1998): Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1. Mol Cell Biol 18:3915-3925.
234. Plotkin LI, Manolagas SC, Bellido T (2002): Transduction of cell survival signals by connexin-43 hemichannels. J Biol Chem 277:8648-8657.
235. Porte D, Tuckermann J, Becker M, Baumann B, Teurich S, Higgins T, Owen MJ, Schorpp-Kistner M, Angel P (1999): Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone. Oncogene 18:667-678.
236. Pratap J, Galindo M, Zaidi SK, Vradii D, Bhat BM, Robinson JA, Choi J-Y, Komori T, Stein JL, Lian JB, Stein GS, van Wijnen AJ (2003): Cell growth regulatory role of Runx2 during proliferative expansion of pre-osteoblasts. Cancer Res 63:5357-5362.
237. Prince M, Banerjee C, Javed A, Green J, Lian JB, Stein GS, Bodine PV, Komm BS (2001): Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J Cell Biochem 80:424-440.
238. Prosser HM, Wotton D, Gegonne A, Ghysdael J, Wang S, Speck NA, Owen MJ (1992): A phorbol ester response element within the human T-cell receptor beta-chain enhancer. Proc Natl Acad Sci U S A 89:9934-9938.
239. Puig-Kroger A, Sanchez-Elsner T, Ruiz N, Andreu EJ, Prosper F, Jensen UB, Gil J, Erickson P, Drabkin H, Groner Y, Corbi AL (2003): RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements. Blood 102: 3252-3261.
240. Qiu M, Bulfone A, Ghattas I, Meneses JJ, Christensen L, Sharpe PT, Presley R, Pedersen RA, Rubenstein JL (1997): Role of the Dlx homeobox genes in proximodistal patterning of the branchial arches: mutations of Dlx-1, Dlx-2, and Dlx-1 and -2 alter morphogenesis of proximal skeletal and soft tissue structures derived from the first and second arches. Dev Biol 185:165-184.
241. Rachez C, Freedman LP (2000): Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions. Gene 246:9-21.
242. Redondo JM, Pfohl JL, Hernandez-Munain C, Wang S, Speck NA, Krangel MS (1992): Indistinguishable nuclear factor binding to functional core sites of the T-cell receptor delta and murine leukemia virus enhancers. Mol Cell Biol 12:4817-4823.
243. Rennert J, Coffman JA, Mushegian AR, Robertson AJ (2003): The evolution of Runx genes I. A comparative study of sequences from phylogenetically diverse model organisms. BMC Evol Biol 3:4.
244. Rice DP, Rice R, Thesleff I (2003): Molecular mechanisms in calvarial bone and suture development, and their relation to craniosynostosis. Eur J Orthod 25:139-148.
245. Robertson AJ, Dickey CE, McCarthy JJ, Coffman JA (2002): The expression of SpRunt during sea urchin embryogenesis. Mech Dev 117:327-330.
246. Robledo RF, Rajan L, Li X, Lufkin T (2002): The Dlx5 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development. Genes Dev 16:1089-1101
247. Rodan SB, Rodan GA (1997): Integrin function in osteoclasts. J Endocrinol 154 Suppl:S47-S56
248. Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Chumakov I, Le Paslier D, Berger R, Bernard OA (1995): The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85:3662-3670.
249. Rossi F, MacLean HE, Yuan W, Francis RO, Semenova E, Lin CS, Kronenberg HM, Cobrinik D (2002): p107 and p130 coordinately regulate proliferation, Cbfa1 expression, and hypertrophic differentiation during endochondral bone development. Dev Biol 247:271-285.
250. Ryoo H-M, Hoffmann HM, Beumer TL, Frenkel B, Towler DA, Stein GS, Stein JL, van Wijnen AJ, Lian JB (1997): Stage-specific expression of Dlx-5 during osteoblast differentiation: involvement in regulation of osteocalcin gene expression. Mol Endocrinol 11: 1681-1694.
251. Sasaki K, Yagi H, Bronson RT, Tominaga K, Matsunashi T, Deguchi K, Tani Y, Kishimoto T, Komori T (1996): Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta. Proc Natl Acad Sci U S A 93:12359-12363.
252. Sasaki-Iwaoka H, Maruyama K, Endoh H, Komori T, Kato S, Kawashima H (1999): A trans-acting enhancer modulates estrogen-mediated transcription of reporter genes in osteoblasts. J Bone Miner Res 14:248-255.
253. Satake M, Nomura S, Yamaguchi-Iwai Y, Takahama Y, Hashimoto Y, Niki M, Kitamura Y, Ito Y (1995): Expression of the Runt domain-encoding PEBP2 alpha genes in T cells during thymic development. Mol Cell Biol 15:1662-1670.
254. Sato M, Morii E, Komori T, Kawahata H, Sugimoto M, Terai K, Shimizu H, Yasui T, Ogihara H, Yasui N, Ochi T, Kitamura Y, Ito Y, Nomura S (1998): Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Oncogene 17:1517-1525.
255. Satokata I, Ma L, Ohshima H, Bei M, Woo I, Nishizawa K, Maeda T, Takano Y, Uchiyama M, Heaney S, Peters H, Tang Z, Maxson R, Maas R (2000): Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet 24:391-395.
256. Scherzinger E, Sittler A, Schweiger K, Heiser V, Lurz R, Hasenbank R, Bates GP, Lehrach H, Wanker EE (1999): Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc Natl Acad Sci U S A 96:4604-4609.
257. Selvamurugan N, Chou WY, Pearman AT, Pulumati MR, Partridge NC (1998): Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence. J Biol Chem 273:10647-10657.
258. Selvamurugan N, Pulumati MR, Tyson DR, Partridge NC (2000): Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor alphal. J Biol Chem 275:5037-5042.
259. Shalhoub V, Bettencourt B, Jackson ME, MacKay CA, Glimcher MJ, Marks SC Jr, Stein GS, Lian JB (1994): Abnormalities of phosphoprotein gene expression in three osteopetrotic rat mutations: elevated mRNA transcripts, protein synthesis, and accumulation in bone of mutant animals. J Cell Physiol 158:110-120.
260. Shalhoub V, Jackson ME, Lian JB, Stein GS, Marks SC Jr (1991): Gene expression during skeletal development in three osteopetrotic rat mutations. Evidence for osteoblast abnormalities. J Biol Chem 266:9847-9856.
261. Shen J, Hovhannisyan H, Lian JB, Montecino MA, Stein GS, Stein JL, van Wijnen AJ (2003): Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones h3 and h4. Mol Endocrinol 17:743-756.
262. Shen J, Montecino MA, Lian JB, Stein GS, van Wijnen AJ, Stein JL (2002): Histone acetylation in vivo at the osteocalcin locus is functionally linked to vitamin D dependent, bone tissue-specific transcription. J Biol Chem 277:20284-20292.
263. Shi MJ, Stavnezer J (1998): CBF alpha3 (AML2) is induced by TGF-beta1 to bind and activate the mouse germline Ig alpha promoter. J Immunol 161:6751-6760.
264. Shi X, Shi W, Li Q, Song B, Wan M, Bai S, Cao X (2003): A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells. EMBO Rep 4:374-380.
265. Shirakabe K, Terasawa K, Miyama K, Shibuya H, Nishida E (2001): Regulation of the activity of the transcription factor Runx2 by two homeobox proteins, Msx2 and Dlx5. Genes Cells 6:851-856.
266. Sierra J, Villagra A, Paredes R, Cruzat F, Gutierrez S, Arriagada G, Olate J, Imschenetzky M, van Wijnen AJ, Lian JB, Stein GS, Stein JL, Montecino M (2003): Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyl transferase activity. Mol Cell Biol 23:3339-3351.
267. Simeone A, Daga A, Calabi F (1995): Expression of runt in the mouse embryo. Dev Dyn 203:61-70.
268. Simmons PJ, Torok-Storb B (1991): Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78:55-62.
269. Skillington J, Choy L, Derynck R (2002): Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J Cell Biol 159:135-146.
270. Speck NA, Gilliland DG (2002): Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer 2: 502-513.
271. Speck NA, Stacy T (1995): A new transcription factor family associated with human leukemias. Crit Rev Eukaryot Gene Expr 5:337-364.
272. Speck NA, Stacy T, Wang Q, North T, Gu TL, Miller J, Binder M, Marin-Padilla M (1999): Core-binding factor: a central player in hematopoiesis and leukemia. Cancer Res 59:1789s-1793s.
273. Spinella-Jaegle S, Rawadi G, Kawai S, Gallea S, Faucheu C, Mollat P, Courtois B, Bergaud B, Ramez V, Blanchet AM, Adelmant G, Baron R, Roman-Roman S (2001): Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation. J Cell Sci 114:2085-2094.
274. Stein GS, Lian JB, Montecino M, van Wijnen AJ, Stein JL, Javed A, Zaidi K (2002): Involvement of nuclear architecture in regulating gene expression in bone cells. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of Bone Biology. San Diego: Academic Press, 169-188.
275. Stein GS, Montecino M, van Wijnen AJ, Stein JL, Lian JB (2000a): Nuclear structure-gene expression interrelationships: implications for aberrant gene expression in cancer. Cancer Res 60:2067-2076.
276. Stein GS, van Wijnen AJ, Stein JL, Lian JB, Montecino M, Choi J-Y, Zaidi K, Javed A (2000b): Intranuclear trafficking of transcription factors: implications for biological control. J Cell Sci 113:2527-2533.
277. Stenoien DL, Patel K, Mancini MG, Dutertre M, Smith CL, O'Malley BW, Mancini MA (2001): FRAP reveals that mobility of oestrogen receptor-alpha is ligand-and proteasome-dependent. Nat Cell Biol 3:15-23.
278. Stewart M, Terry A, Hu M, O'Hara M, Blyth K, Baxter E, Cameron E, Onions DE, Neil JC (1997): Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene. Proc Natl Acad Sci U S A 94:8646-8651.
279. Stifani S, Blaumueller CM, Redhead NJ, Hill RE, Artavanis-Tsakonas S (1992): Human homologs of a Drosophila enhancer of split gene product define a novel family of nuclear proteins. Nat Genet 2:119-127.
280. Stock M, Schafer H, Stricker S, Gross G, Mundlos S, Otto F (2003): Expression of galectin-3 in skeletal tissues is controlled by Runx2. J Biol Chem 278:17360-17367.
281. Stricker S, Fundele R, Vortkamp A, Mundlos S (2002): Role of runx genes in chondrocyte differentiation. Dev Biol 245:95-108.
282. Stupack DG, Cheresh DA (2002): Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci 115:3729-3738.
283. Suda T, Ueno Y, Fujii K, Shinki T (2003): Vitamin D and bone. J Cell Biochem 88:259-266.
284. Sudhakar S, Li Y, Katz MS, Elango N (2001): Translational regulation is a control point in RUNX2/Cbfa1 gene expression. Biochem Biophys Res Commun 289:616-622.
285. Sudol M, Hunter T (2000): NeW wrinkles for an old domain. Cell 103:1001-1004.
286. Sun L, Vitolo M, Passaniti A (2001): Runt-related gene 2 in endothelial cells: inducible expression and specific regulation of cell migration and invasion. Cancer Res 61:4994-5001.
287. Suzawa M, Takada I, Yanagisawa J, Ohtake F, Ogawa S, Yamauchi T, Kadowaki T, Takeuchi Y, Shibuya H, Gotoh Y, Matsumoto K, Kato S (2003): Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade. Nat Cell Biol 5:224-230.
288. Swarthout JT, D'Alonzo RC, Selvamurugan N, Partridge NC (2002): Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene 282:1-17.
289. Tadic T, Dodig M, Erceg I, Marijanovic I, Mina M, Kalajzic Z, Velonis D, Kronenberg MS, Kosher RA, Ferrari D, Lichtler AC (2002): Overexpression of Dlx5 in chicken calvarial cells accelerates osteoblastic differentiation. J Bone Miner Res 17:1008-1014.
290. Takahashi A, Satake M, Yamaguchi-Iwai Y, Bae SC, Lu J, Maruyama M, Zhang YW, Oka H, Arai N, Arai K-I, Ito Y (1995): Positive and negative regulation of granulocyte-macrophage colony stimulating factor promoter activity by AML1-related transcription factor, PEBP2. Blood 86:607-616.
291. Takamoto M, Tsuji K, Yamashita T, Sasaki H, Yano T, Taketani Y, Komori T, Nifuji A, Noda M (2003): Hedgehog signaling enhances core-binding factor a1 and receptor activator of nuclear factor-kappaB ligand (RANKL) gene expression in chondrocytes. J Endocrinol 177:413-421.
292. Takeda S, Bonnamy JP, Owen MJ, Ducy P, Karsenty G (2001): Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev 15:467-481.
293. Tang L, Guo B, Javed A, Choi J-Y, Hiebert S, Lian JB, van Wijnen AJ, Stein JL, Stein GS, Zhou GW (1999): Crystal structure of the nuclear matrix targeting signal of the transcription factor AML-1/PEBP2αB/CBFα2. J Biol Chem 274:33580-33586.
294. Tang L, Guo B, van Wijnen AJ, Lian JB, Stein JL, Stein GS, Zhou GW (1998): Preliminary crystallographic study of the glutathione S-transferase fused with the nuclear matrix targeting signal of the transcription factor AML-1/CBFa2. J Struct Biol 123:83-85.
295. Tang QQ, Otto TC, Lane MD (2003): CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis. Proc Natl Acad Sci U S A 100:850-855.
296. Taniuchi I, Osato M, Egawa T, Sunshine MJ, Bae SC, Komori T, Ito Y, Littman DR (2002): Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111:621-633.
297. Teitelbaum SL, Tondravi MM, Ross FP (1996): Osteoclast biology. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. San Diego: Academic Press, Inc., pp. 61-94.
298. Thirunavukkarasu K, Halladay DL, Miles RR, Yang X, Galvin RJ,
299. Thirunavukkarasu K, Mahajan M, McLarren KW, Stifani S, Karsenty G (1998): Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbf beta. Mol Cell Biol 18: 4197-4208.
300. Thomas DM, Carty SA, Piscopo DM, Lee JS, Wang WF, Forrester WC, Hinds PW (2001): The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol Cell 8:303-316.
301. Thomas M, Dadgar N, Aphale A, Harrell JM, Kunkel R, Fu M, Pestell R, Pratt WB, Lieberman AP (2004): Androgen receptor acetylation site mutations cause trafficking defects, misfolding and aggregation similar to expanded glutamine tracts. J Biol Chem 279:8389-8395.
302. Tintut Y, Parhami F, Le V, Karsenty G, Demer LL (1999): Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin/proteasome-dependent regulation. J Biol Chem 274:28875-28879.
303. Tou L, Quibria N, Alexander JM (2001): Regulation of human cbfa1 gene transcription in osteoblasts by selective estrogen receptor modulators (SERMs). Mol Cell Endocrinol 183:71-79.
304. Towler DA, Rutledge SJ, Rodan GA (1994): Msx-2/Hox 8.1: a transcriptional regulator of the rat osteocalcin promoter. Mol Endocrinol 8:1484-1493.
305. Tribioli C, Lufkin T (1999): The murine Bapx1 homeobox gene plays a critical role in embryonic development of the axial skeleton and spleen. Development 126:5699-5711.
306. Tsuji K, Noda M (2001): Transient suppression of core-binding factor alpha 1 expression by basic fibroblast growth factor in rat osteoblast-like osteosarcoma ROS17/2.8 cells. J Bone Miner Metab 19:213-219.
307. Tuli R, Tuli S, Nandi S, Huang X, Manner PA, Hozack WJ, Danielson KG, Hall DJ, Tuan RS (2003): Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and MAP kinase and Wnt signaling crosstalk. J Biol Chem 278:41227-41236.
308. Turner RT, Colvard DS, Spelsberg TC (1990): Estrogen inhibition of periosteal bone formation in rat long bones: down-regulation of gene expression for bone matrix proteins. Endocrinology 127:1346-1351.
309. Ueta C, Iwamoto M, Kanatani N, Yoshida C, Liu Y, Enomoto-Iwamoto M, Ohmori T, Enomoto H, Nakata K, Takada K, Kurisu K, Komori T (2001): Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes. J Cell Biol 153:87-100.
310. Vaillant F, Blyth K, Andrew L, Neil JC, Cameron ER (2002): Enforced expression of Runx2 perturbs T cell development at a stage coincident with beta-selection. J Immunol 169:2866-2874.
311. Vaillant F, Blyth K, Terry A, Bell M, Cameron ER, Neil J, Stewart M (1999): A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc. Oncogene 18:7124-7134.
312. van Wijnen AJ, Bidwell JP, Fey EG, Penman S, Lian JB, Stein JL, Stein GS (1993): Nuclear matrix association of multiple sequence-specific DNA binding activities related to SP-1, ATF, CCAAT, C/EBP, OCT-1, and AP-1. Biochemistry 32:8397-8402.
313. Viereck V, Siggelkow H, Tauber S, Raddatz D, Schutze N, Hufner M (2002): Differential regulation of Cbfa1/ Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts. J Cell Biochem 86:348-356.
314. Wagner EF, Karsenty G (2001): Genetic control of skeletal development. Curr Opin Genet Dev 11:527-532.
315. Waki T, Tamura G, Sato M, Terashima M, Nishizuka S, Motoyama T (2003): Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci 94:360-364.
316. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA (1996a): Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci U S A 93:3444-3449.
317. Wang Q, Stacy T, Miller JD, Lewis AF, Gu TL, Huang X, Bushweller JH, Bories JC, Alt FW, Ryan G, Liu PP, Wynshaw-Boris A, Binder M, Marin-Padilla M, Sharpe AH, Speck NA (1996b): The CBFbeta subunit is essential for Cbfalpha2 (AML1) function in vivo. Cell 87:697-708.
318. Wang S, Wang Q, Crute BE, Melnikova IN, Keller SR, Speck NA (1993): Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol Cell Biol 13: 3324-3339.
319. Wang WF, Wang YG, Reginato AM, Plotkina S, Gridley T, Olsen BR (2002): Growth defect in Grg5 null mice is associated with reduced Ihh signaling in growth plates. Dev Dyn 224:79-89.
320. Wee HJ, Huang G, Shigesada K, Ito Y (2002): Serine phosphorylation of RUNX2 with novel potential functions as negative regulatory mechanisms. EMBO Rep 3:967-974.
321. Westendorf JJ, Hiebert SW (1999): Mammalian runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia. J Cell Biochem Suppl 32-33:51-58.
322. Westendorf JJ, Yamamoto CM, Lenny N, Downing JR, Selsted ME, Hiebert SW (1998): The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation. Mol Cell Biol 18:322-333.
323. Westendorf JJ, Zaidi SK, Cascino JE, Kahler R, van Wijnen AJ, Lian JB, Yoshida M, Stein GS, Li X (2002): Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Mol Cell Biol 22:7982-7992.
324. Wheeler JC, Shigesada K, Gergen JP, Ito Y (2000): Mechanisms of transcriptional regulation by Runt domain proteins. Semin Cell Dev Biol 11:369-375.
325. Wijmenga C, Speck NA, Dracopoli NC, Hofker MH, Liu P, Collins FS (1995): Identification of a new murine runt domain-containing gene, Cbfa3, and localization of the human homolog, CBFA3, to chromosome 1p35-pter. Genomics 26:611-614.
326. Wilkie AO, Tang Z, Elanko N, Walsh S, Twigg SR, Hurst JA, Wall SA, Chrzanowska KH, Maxson RE Jr (2000): Functional haploinsufficiency of the human homeobox gene MSX2 causes defects in skull ossification. Nat Genet 24:387-390.
327. Woodiel FN, Fall PM, Raisz LG (1996): Anabolic effects of prostaglandins in cultured fetal rat calvariae: structure-activity relations and signal transduction pathway. J Bone Miner Res 11:1249-1255.
328. Workman JL, Kingston RE (1998): Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu Rev Biochem 67:545-579.
329. Wrana JL (2000a): Crossing Smads. Sci STKE 2000:RE1.
330. Wrana JL (2000b): Regulation of Smad activity. Cell 100: 189-192.
331. Xiao G, Gopalkrishnan RV, Jiang D, Reith E, Benson MD, Franceschi R (2002a): Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 17:101-110.
332. Xiao G, Jiang D, Gopalakrishnan R, Franceschi RT (2002b): Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J Biol Chem 277:36181-36187.
333. Xiao G, Jiang D, Thomas P, Benson MD, Guan K, Karsenty G, Franceschi RT (2000): MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J Biol Chem 275:4453-4459.
334. Xiao ZS, Hinson TK, Quarles LD (1999): Cbfa1 isoform overexpression upregulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells. J Cell Biochem 74:596-605.
335. Xiao ZS, Liu SG, Hinson TK, Quarles LD (2001): Characterization of the upstream mouse Cbfa1/Runx2 promoter. J Cell Biochem 82:647-659.
336. Xiao ZS, Simpson LG, Quarles LD (2003): IRES-dependent translational control of Cbfa1/Runx2 expression. J Cell Biochem 88:493-505.
337. Xiao ZS, Thomas R, Hinson TK, Quarles LD (1998): Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor. Gene 214:187-197.
338. Yagi R, Chen LF, Shigesada K, Murakami Y, Ito Y (1999): A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J 18:2551-2562.
339. Yamamoto N, Akiyama S, Katagiri T, Namiki M, Kurokawa T, Suda T (1997): Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem Biophys Res Commun 238:574-580.
340. Yamashiro T, Aberg T, Levanon D, Groner Y, Thesleff I (2002): Expression of Runx1, -2 and -3 during tooth, palate and craniofacial bone development. Mech Dev 119:S107-S110
341. Yang N, Zhang L, Zhang Y, Kazazian HH Jr (2003a): An important role for RUNX3 in human L1 transcription and retrotransposition. Nucleic Acids Res 31:4929-4940.
342. Yang S, Wei D, Wang D, Phimphilai M, Krebsbach PH, Franceschi RT (2003b): In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res 18:705-715.
343. Yang Y, Yu X (2003): Regulation of apoptosis: the ubiquitous way. FASEB J 17:790-799.
344. Yergeau DA, Hetherington CJ, Wang Q, Zhang P, Sharpe AH, Binder M, Marin-Padilla M, Tenen DG, Speck NA, Zhang DE (1997): Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat Genet 15:303-306.
345. Ying SX, Hussain ZJ, Zhang YE (2003): Smurf1 facilitates myogenic differentiation and antagonizes bone morphogenetic protein-2-induced osteoblast conversion by targeting Smad5 for degradation. J Biol Chem 278: 39029-39036.
346. Yoshida CA, Furuichi T, Fujita T, Fukuyama R, Kanatani N, Kobayashi S, Satake M, Takada K, Komori T (2002): Core-binding factor beta interacts with Runx2 and is required for skeletal development. Nat Genet 32:633-638.
347. Yousfi M, Lasmoles F, Kern B, Marie PJ (2002): TWIST inactivation reduces CBFA1/RUNX2 expression and DNA binding to the osteocalcin promoter in osteoblasts. Biochem Biophys Res Commun 297:641-644.
348. Yousfi M, Lasmoles F, Lomri A, Delannoy P, Marie PJ (2001): Increased bone formation and decreased osteocalcin expression induced by reduced Twist dosage in Saethre-Chotzen syndrome. J Clin Invest 107: 1153-1161.
349. Zaidi SK, Javed A, Choi J-Y, van Wijnen AJ, Stein JL, Lian JB, Stein GS (2001a): A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J Cell Sci 114: 3093-3102.
350. Zaidi SK, Sullivan AJ, Ito Y, van Wijnen AJ, Stein JL, Stein GS, Lian JB (2001b): The Yes-associated protein (YAP) is a suppressor of Runx2/Cbfa1 dependent activation of the bone specific osteocalcin gene. J Bone Miner Res 16:S205(Abstract).
351. Zaidi SK, Sullivan AJ, Medina R, Ito Y, van Wijnen AJ, Stein JL, Lian JB, Stein GS (2004): Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J 23:790-799.
352. Zaidi SK, Sullivan AJ, van Wijnen AJ, Stein JL, Stein GS, Lian JB (2002): Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc Natl Acad Sci U S A 99:8048-8053.
353. Zaidi SK, Young DW, Pockwinse SH, Javed A, Lian JB, Stein JL, van Wijnen AJ, Stein GS (2003): Mitotic partitioning and selective reorganization of tissue specific transcription factors in progeny cells. Proc Natl Acad Sci U S A 100:14852-14857.
354. Zambotti A, Makhluf H, Shen J, Ducy P (2002): Characterization of an osteoblast-specific enhancer element in the CBFA1 gene. J Biol Chem 277:41497-41506.
355. Zannettino AC, Harrison K, Joyner CJ, Triffitt JT, Simmons PJ (2003): Molecular cloning of the cell surface antigen identified by the osteoprogenitor-specific monoclonal antibody, HOP-26. J Cell Biochem 89:56-66.
356. Zelzer E, Glotzer DJ, Hartmann C, Thomas D, Fukai N, Soker S, Olsen BR (2001): Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev 106:97-106.
357. Zeng C, McNeil S, Pockwinse S, Nickerson JA, Shopland L, Lawrence JB, Penman S, Hiebert SW, Lian JB, van Wijnen AJ, Stein JL, Stein GS (1998): Intranuclear targeting of AML/CBFa regulatory factors to nuclear matrix-associated transcriptional domains. Proc Natl Acad Sci U S A 95:1585-1589.
358. Zeng C, van Wijnen AJ, Stein JL, Meyers S, Sun W, Shopland L, Lawrence JB, Penman S, Lian JB, Stein GS, Hiebert SW (1997): Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBFα transcription factors. Proc Natl Acad Sci U S A 94:6746-6751.
359. Zeng L, Kempf H, Murtaugh LC, Sato ME, Lassar AB (2002): Shh establishes an Nkx3.2/Sox9 autoregulatory loop that is maintained by BMP signals to induce somitic chondrogenesis. Genes Dev 16:1990-2005.
360. Zhang DE, Fujioka K, Hetherington CJ, Shapiro LH, Chen HM, Look AT, Tenen DG (1994): Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Mol Cell Biol 14:8085-8095.
361. Zhang DE, Hetherington CJ, Meyers S, Rhoades KL, Larson CJ, Chen HM, Hiebert SW, Tenen DG (1996): CCAAT enhancer-binding protein (C/EBP) and AML1 (CBFα2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol Cell Biol 16:1231-1240.
362. 3 inhibits osteocalcin expression in mouse through an indirect mechanism. J Biol Chem 272:110-116.
363. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ (2002): Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109:1405-1415.
364. Zhang Y, Derynck R (1999): Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol 9:274-279.
365. Zhang YW, Bae SC, Huang G, Fu YX, Lu J, Ahn MY, Kanno Y, Kanno T, Ito Y (1997b): A novel transcript encoding an N-terminally truncated AML1/PEBP2 alphaB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells. Mol Cell Biol 17:4133-4145.
366. Zhang YW, Yasui N, Ito K, Huang G, Fujii M, Hanai J, Nogami H, Ochi T, Miyazono K, Ito Y (2000): A RUNX2/PEBP2αA/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci U S A 97: 10549-10554.
367. Zhao M, Qiao M, Oyajobi BO, Mundy GR, Chen D (2003): E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation. J Biol Chem 278:27939-27944.
368. Zheng Q, Zhou G, Morello R, Chen Y, Garcia-Rojas X, Lee B (2003): Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J Cell Biol 162:833-842.
369. Zhou YX, Xu X, Chen L, Li C, Brodie SG, Deng CX (2000): A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum Mol Genet 9:2001-2008.